Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS StudyArticle Published on 2024-07-172024-09-05 Journal: Vaccines [Category] update2024, [키워드] Cell mediated immunity Humoral immunity passive pre-prophylaxis SARS Coronavirus [DOI] 10.3390/vaccines12070784 PMC 바로가기 [Article Type] Article
Risks associated with acute pancreatitis (AP) with diabetic ketoacidosis (DKA) in COVID-19 patients: a literature reviewReview Article Published on 2023-04-082024-09-05 Journal: Journal of Diabetes and Metabolic Disorders [Category] update2024, [키워드] Acute kidney injury acute pancreatitis COVID-19 diabetes diabetic ketoacidosis healthcare SARS Coronavirus [DOI] 10.1007/s40200-023-01207-3 PMC 바로가기 [Article Type] Review Article
Low prevalence of influenza viruses and predominance of A(H3N2) virus with respect to SARS‐CoV‐2 during the 2021–2022 season in BulgariaResearch Article Published on 2023-01-232024-09-05 Journal: Journal of medical virology [Category] update2024, [키워드] Epidemiology Infection Influenza virus SARS Coronavirus vaccines/vaccine strains [DOI] 10.1002/jmv.28489 PMC 바로가기 [Article Type] Research Article
Varicella zoster virus reactivation following COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: A cross-sectional Chinese study of 318 casesCOVID-19 백신 접종 후 자가면역 염증성 류마티스 질환 환자에서 수두 대상포진 바이러스 재활성화: 318건의 중국 단면 연구Article Published on 2023-01-012023-05-31 Journal: Journal of medical virology [Category] B형 간염, Fulltext, 두창, 수두, 홍역, [키워드] autoimmune inflammatory rheumatic diseases COVID-19 vaccine SARS Coronavirus varicella-zoster virus reactivation. [DOI] 10.1002/jmv.28307 PMC 바로가기
GETTING AHEAD OF MONKEYPOX: Learning from the COVID-19 pandemic experience to prevent the potentially new monkeypox pandemic원숭이두창 앞서가기: 잠재적인 새로운 원숭이두창 팬데믹을 예방하기 위해 COVID-19 팬데믹 경험에서 배우기Article Published on 2023-01-012023-06-10 Journal: Journal of medical virology [Category] 원숭이두창, [키워드] Epidemiology Pandemics poxvirus SARS Coronavirus virus classification [DOI] 10.1002/jmv.28146
SARS-CoV-2 ORF3a inhibits cGAS-STING-mediated autophagy flux and antiviral functionArticle Published on 2023-01-012023-07-10 Journal: Journal of medical virology [Category] COVID19(2023년), [키워드] coronavirus immune responses Innate immunity SARS Coronavirus virus classification [DOI] 10.1002/jmv.28175 PMC 바로가기
Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological ExpansionArticle Published on 2022-12-032023-07-11 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), [키워드] BQ.1 coronavirus Epidemiology Pandemics SARS Coronavirus virus classification [DOI] 10.3390/ijms232315264 PMC 바로가기
Initial introduction and spread of the SARS-CoV-2 AY.4.2.1 Delta variant in Bulgaria, a genomic insightArticle Published on 2022-12-012022-11-16 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, [키워드] A222V accelerated Bulgaria COVID-19 pandemic delta variant dissemination Epidemiology Evolution genomic Mutation mutation/mutation rate. mutations raise SARS Coronavirus SARS-CoV-2 variant Spread the SARS-CoV-2 the spike protein Transmission United Kingdom variant [DOI] 10.1002/jmv.28033 PMC 바로가기
What are the long-term holistic health consequences of COVID-19 among survivors? An umbrella systematic reviewArticle Published on 2022-12-012022-11-16 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, [키워드] acute COVID-19 acute phase acute respiratory syndrome affected conducted consequence coronavirus COVID-19 COVID-19 treatments demographic data determine eligibility criteria employment Epidemiology fatigue functional Health Impact individual Laboratory parameters memory Pandemics Participants physical Psychological psychological impacts Quality of life ranged Research respiratory symptoms Sample SARS Coronavirus screened survived Survivors systematic review systematic reviews variant virus virus classification [DOI] 10.1002/jmv.28086 PMC 바로가기
Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cellsArticle Published on 2022-11-022022-11-15 Journal: Scientific Reports [Category] SARS, 치료제, [키워드] Antiviral antivirals approved drug caused clinical evaluation Combination Compound concentrations conducted COVID-19 drug Effect Efficacy epithelial cell line exonuclease global pandemic HCV hepatitis C human lung human lung cell identify inhibitor moderate morbidity Mortality NS5A pharmacokinetic profiles Protein Remdesivir SARS Coronavirus SARS-CoV-2 SARS-CoV-2 replication Support synergy the SARS-CoV-2 therapeutic treatment strategy virus [DOI] 10.1038/s41598-022-21034-5 PMC 바로가기